日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Sustained glucagon-like peptide-1 receptor agonist treatment improves glycemic control and reduces all-cause mortality compared to dipeptidyl peptidase-4 inhibitors: A real-world target trial emulation in type 2 diabetes

与二肽基肽酶-4抑制剂相比，持续使用胰高血糖素样肽-1受体激动剂治疗可改善血糖控制并降低全因死亡率：一项针对2型糖尿病患者的真实世界目标试验模拟研究

期刊:Diabetes Obesity & Metabolism
影响因子:5.7
doi:10.1111/dom.70581
Sørensen, Kathrine Kold; Yazdanfard, Puriya Daniel Würtz; Zareini, Bochra; Wood-Kurland, Hannah Karin; Pedersen-Bjergaard, Ulrik; Andersen, Mikkel Porsborg; Michelsen, Jens; Imberg, Henrik; Lind, Marcus; Hallström, Sara; Lanzinger, Stefanie; Munch, Anders; Ohlendorff, Johan Sebastian; Gerds, Thomas Alexander; Torp-Pedersen, Christian
糖尿病
信号转导
代谢
发表日期：2026
文献求助 收藏

Factors influencing the progression of post-mortem changes between scene and autopsy

影响现场与尸检之间尸体变化进程的因素

期刊:Scientific Reports
影响因子:3.9
doi:10.1038/s41598-026-35786-x
Lanzinger, Nina; Verhoff, Marcel A; Birngruber, Christoph G; Lutz, Lena
发表日期：2026
文献求助 收藏

A worldwide perspective on clinical characteristics and treatment of youth with monogenic diabetes in the SWEET registry

SWEET注册研究中单基因糖尿病青少年患者的临床特征和治疗的全球视角

期刊:Journal of the Endocrine Society
影响因子:3.1
doi:10.1210/jendso/bvag064
Deng, Lily; Lanzinger, Stefanie; Casteels, Kristina; Cavallo, Fred; De Sanctis, Luisa; Fitas, Ana Laura; Huang, Carol; Kim, Jaehyun; Patouni, Konstantina; Pruhova, Stepanka; Taplin, Craig E; Tauschmann, Martin; Krishnamurthy, Mansa
糖尿病
代谢
发表日期：2026
文献求助 收藏

Type 1 Diabetes and Other Autoimmune Diseases-Epidemiology, Pathophysiology and Screening

1型糖尿病和其他自身免疫性疾病——流行病学、病理生理学和筛查

期刊:Endocrinology, Diabetes and Metabolism
影响因子:2.6
doi:10.1002/edm2.70119
Kahaly, George J; Forst, Thomas; Kellerer, Monika; Lanzinger, Stefanie; Rötzer, René D; Schott, Matthias; Schumm-Draeger, Petra-Maria
代谢
糖尿病
自身免疫性疾病
免疫/内分泌
发表日期：2026
文献求助 收藏

GLP-1 receptor agonists or SGLT2-inhibitors? Evaluation of a personalized treatment algorithm for individuals with type 2 diabetes: a registry-based cohort study

GLP-1受体激动剂还是SGLT2抑制剂？评估2型糖尿病患者的个体化治疗方案：一项基于注册登记的队列研究

期刊:Experimental and Clinical Endocrinology & Diabetes
影响因子:1.7
doi:10.1055/a-2798-6496
Mori, Tim; Kuß, Oliver; Mader, Julia K; Naudorf, Michael; Seufert, Jochen; Holl, Reinhard W; Lanzinger, Stefanie; Grimsmann, Julia M
SGLT2
GLP-1
信号转导
代谢
糖尿病
发表日期：2026
文献求助 收藏

Type 2 diabetes, sodium-glucose cotransporter-2 inhibitors and cardiovascular outcomes: real world evidence versus a randomised clinical trial

2型糖尿病、钠-葡萄糖协同转运蛋白2抑制剂与心血管结局：真实世界证据与随机临床试验的比较

期刊:Cardiovascular Diabetology
影响因子:10.6
doi:10.1186/s12933-025-02924-0
Yazdanfard, Puriya Daniel Würtz; Sørensen, Kathrine Kold; Zareini, Bochra; Pedersen-Bjergaard, Ulrik; Ohlendorff, Johan Sebastian; Munch, Anders; Andersen, Mikkel Porsborg; Hasselbalch, Rasmus Bo; Imberg, Henrik; Tasseleus, Viktor; Lind, Marcus; Valabhji, Jonathan; Choudhary, Pratik; Khunti, Kamlesh; Schmid, Stefanie; Lanzinger, Stefanie; Mader, Julia; Gerds, Thomas Alexander; Torp-Pedersen, Christian
糖尿病
代谢
发表日期：2025
文献求助 收藏

Real-world cardiovascular effectiveness of sustained glucagon-like peptide 1 GLP-1 receptor agonist usage in type 2 diabetes

2型糖尿病患者持续使用胰高血糖素样肽-1 (GLP-1) 受体激动剂的真实世界心血管疗效

期刊:Cardiovascular Diabetology
影响因子:10.6
doi:10.1186/s12933-025-02915-1
Sørensen, Kathrine Kold; Yazdanfard, Puriya Daniel Würtz; Zareini, Bochra; Pedersen-Bjergaard, Ulrik; Kosjerina, Vanja; Andersen, Mikkel Porsborg; Munch, Anders; Ohlendorff, Johan Sebastian; Schmid, Stefanie; Lanzinger, Stefanie; Choudhary, Pratik; Gillies, Clare; Gharibzadeh, Safoora; Lind, Marcus; Tasselius, Viktor; Michelsen, Jens; Gerds, Thomas Alexander; Torp-Pedersen, Christian
糖尿病
信号转导
GLP-1
代谢
发表日期：2025
文献求助 收藏

Global Inequities in Diabetes Technology and Insulin Access and Glycemic Outcomes

全球糖尿病技术、胰岛素获取及血糖控制结果方面的不平等

期刊:Jama Network Open
影响因子:9.7
doi:10.1001/jamanetworkopen.2025.28933
Santova, Alzbeta; de Bock, Martin; Lanzinger, Stefanie; Goldbloom, Ellen B; Bratina, Natasa; Barcala, Consuelo; Alhomaidah, Doha; Pande, Arunkumar R; Guness, Pravesh Kumar; Dzivite-Krisane, Iveta; Limbert, Catarina; Sumnik, Zdenek
代谢
糖尿病
免疫/内分泌
发表日期：2025
文献求助 收藏

Analysis of patient characteristics and safety of insulin glargine U300 use in 21 359 patients with type-2 diabetes and chronic kidney disease: DPV registry study

对 21359 例合并慢性肾脏病的 2 型糖尿病患者使用甘精胰岛素 U300 的患者特征和安全性进行分析：DPV 注册研究

期刊:Diabetes Obesity & Metabolism
影响因子:5.7
doi:10.1111/dom.16245
Vijayan, Anjaly; Lanzinger, Stefanie; Forestier, Nicole; Hess, Gregor; Rottmann, Marcus; Wosch, Frank J; Seufert, Jochen; Holl, Reinhard W; Bramlage, Peter
代谢
糖尿病
免疫/内分泌
发表日期：2025
文献求助 收藏

Impact of the COVID-19 Pandemic on Psychosocial Distress in Adolescents with Obesity Compared to Those with Type 1 Diabetes: Results from the KICK-COVID Study in Germany

新冠肺炎疫情对肥胖青少年和1型糖尿病青少年心理社会困扰的影响：来自德国KICK-COVID研究的结果

期刊:Obesity Facts
影响因子:4.7
doi:10.1159/000542756
Weihrauch-Blüher, Susann; Wiegand, Susanna; Tittel, Sascha; Greber-Platzer, Susanne; Lanzinger, Stefanie; Kamrath, Clemens; Minden, Kirsten; Sengler, Claudia; Linke, Sabine; Büssenschütt, Antje; Reschke, Felix; Göldel, Julia; Warschburger, Petra; Holl, Reinhard W
肺炎
新冠
代谢
微生物学
肥胖
糖尿病
发表日期：2025
文献求助 收藏